Laterality in the histological effects of injections of amyloid-β 25- 35 into the amygdala of young Fischer rats

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 6, 1997, Pages 714-725

  Sigurdsson, Einar M ^a   Lee, John M ^a   Dong, Xin W ^a   Hejna, Matthew J ^a   Lorens, Stanley A ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amygdala; Amyloid protein; GFAP; Hippocampus; Laterality; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SENILE PLAQUE;

EID: 0030732756     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199706000-00009     Document Type: Article

References (91)

1. Glenner GG, Wong CW. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-90
2. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985;82:4245-49
3. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 1993;301:41-52
4. Roher AE, Lowenson JD, Clarke S, et al. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993;268:3072-83
5. Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-36
6. Suzuki N, Cheung TT, Cai XD, et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 1994;264:1336-40
7. Cai XD, Golde TE, Younkin SG. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 1993;259:514-16
8. Citron M, Oltersdorf T, Haass C, et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 1992;360:672-74
9. Neve RL, Finch EA, Dawes LR. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron 1988;1: 669-77
10. Rumble B, Retallack R, Hilbich C, et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 1989;320:1446-52
11. Burger PC, Vogel FS. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am J Pathol 1973;73:457-76
12. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989;46:849-53
13. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 1990;250:279-82
14. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989;245:417-20
15. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 1991;563:311-14
16. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 1993;13:1676-87
17. Lorenzo A, Yankner BA. β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA 1994;91:12243-47
18. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O. Neurotoxicity of a prion protein fragment. Nature 1993;362: 543-46
19. May PC, Boggs LN, Fuson KS. Neurotoxicity of human amylin in rat primary hippocampal cultures: Similarity to Alzheimer's disease amyloid-β neurotoxicity. J Neurochem 1993;61:2330-33
20. Lorenzo A, Razzaboni B, Weir GC, Yankner BA. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994;368:756-60
21. Urbanyi Z, Lakics V, Erdo SL. Serum amyloid P component-induced cell death in primary cultures of rat cerebral cortex. Eur J Pharmacol 1994;270:375-78
22. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995;373:523-27
23. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 1996;274:99-102
24. Terry RD. The fine structure of neurofibrillary tangles in Alzheimer's disease. J Neuropathol Exp Neurol 1963;22:629-42
25. Kidd M. Alzheimer's disease. An electron microscopical study. Brain 1964;87:307-20
26. Kondo J, Honda T, Mori H, et al. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1988;1:827-34
27. Ksiezak-Reding H, Chien CH, Lee VM, Yen SH. Mapping of the Alz 50 epitope in microtubule-associated proteins tau. J Neurosci Res 1990;25:412-19
28. Wischik CM, Novak M, Thogersen HC, et al. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci USA 1988;85:4506-10
29. Wischik CM, Novak M, Edwards PC, Klug A, Tichelaar W, Crowther RA. Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci USA 1988;85:4884-88
30. Takashima A, Noguchi K, Sato K, Hoshino T, Imahori K. Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity. Proc Natl Acad Sci USA 1993;90:7789-93
31. Busciglio J, Lorenzo A, Yeh J, Yankner BA. β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995;14:879-88
32. Malouf AT. Effect of β amyloid peptides on neurons in hippocampal slice cultures. Neurobiol Aging 1992;13:543-51
33. Frautschy SA, Baird A, Cole GM. Effects of injected Alzheimer β-amyloid cores in rat brain. Proc Natl Acad Sci USA 1991;88: 8362-66
34. Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc Natl Acad Sci USA 1991;88:7247-51
35. Kowall NW, McKee AC, Yankner BA, Beal MF. In vivo neurotoxicity of β-amyloid (β [1-40]) and the β(25-35) fragment. Neurobiol Aging 1992;13:537-42
36. Sigurdsson EM, Lorens SA, Hejna MJ, Dong X-W, Lee JM. Local and distant histopathological effects of unilateral amyloid-β 25-35 injections into the amygdala of young F344 rats. Neurobiol Aging 1996;17:893-901
37. Shin RW, Bramblett GT, Lee VM, Trojanowski JQ. Alzheimer disease A68 proteins injected into rat brain induce codeposits of β-amyloid, ubiquitin, and alpha 1-antichymotrypsin. Proc Natl Acad Sci USA 1993;90:6825-28
38. Duffy PE, Rapport M, Graf L. Glial fibrillary acidic protein and Alzheimer-type senile dementia. Neurology 1980;30:778-82
39. Eng LF, Vanderhaeghen JJ, Bignami A, Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res 1971;28:351-54
40. Buee L, Laine A, Delacourte A, Flament S, Han KK. Qualitative and quantitative comparison of brain proteins in Alzheimer's disease. Biol Chem Hoppe Seyler 1989;370:1229-34
41. Delacourte A. General and dramatic glial reaction in Alzheimer brains. Neurology 1990;40:33-37
42. Pike CJ, Cummings BJ, Monzavi R, Cotman CW. β-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 1994;63:517-31
43. Canning DR, McKeon RJ, DeWitt DA, et al. β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal out-growth. Exp Neurol 1993;124:289-98
44. Hoke A, Canning DR, Malemud CJ, Silver J. Regional differences in reactive gliosis induced by substrate-bound β-amyloid. Exp Neurol 1994:130:56-66
45. Pearson RCA, Powell TPS. The neuroanatomy of Alzheimer's disease. Rev Neurosci 1989;2:101-22
46. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. San Diego,CA: Academic Press, 1986
47. Sigurdsson EM, Hejna MJ, Lee JM, et al. β-amyloid 25-35 and/or quinolinic acid injections into the basal forebrain of young male Fischer-344 rats: Behavioral, neurochemical and histological effects. Behav Brain Res 1995;72:141-56
48. Clemens JA, Stephenson DT. Implants containing β-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol Aging 1992;13:581-86
49. Games D, Khan KM, Soriano FG, Keim PS, Davis DL, Bryant K. Lack of Alzheimer pathology after β-amyloid protein injections in rat brain. Neurobiol Aging 1992;13:569-76
50. Giordano T, Pan JB, Monteggia LM, et al. Similarities between β amyloid peptides 1-40 and 40-1: Effects on aggregation, toxicity in vitro, and injection in young and aged rats. Exp Neurol 1994;125: 175-82
51. Giovannelli L, Casamenti F, Scali C, Bartolini L, Pepeu G. Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience 1995;66:781-92
52. Smyth MD, Kesslak JP, Cummings BJ, Cotman CW. Analysis of brain injury following intrahippocampal administration of β-amyloid in streptozotocin-treated rats. Neurobiol Aging 1994;15: 153-59
53. Winkler J, Connor DJ, Frautschy SA, et al. Lack of long-term effects after β-amyloid protein injections in rat brain. Neurobiol Aging 1994;15:601-7
54. Busciglio J, Lorenzo A, Yankner BA. Methodological variables in the assessment of β amyloid neurotoxicity. Neurobiol Aging 1992;13:609-12
55. Schubert D. The possible role of adhesion in synaptic modification. Trends Neurosci 1991;14:127-30
56. Snow AD, Sekiguchi R, Nochlin D, et al. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain. Neuron 1994;12:219-34
57. Nordstedt C, Naslund J, Tjernberg LO, Karlstrom AR, Thyberg J. The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils. J Biol Chem 1994;269: 30773-76
58. Inestrosa NC, Alvarez A, Perez CA, et al. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimers fibrils: Possible role of the peripheral site of the enzyme. Neuron 1996; 16: 881-91
59. Price JL, Russcehn FT, Amaral DG. The limbic region. II: The amygdaloid complex. In: Bjorklund A, Hokfelt T, Swanson LW, eds. Handbook of chemical neuroanatomy. Amsterdam: Elsevier Science Publishers, 1987:279-388
60. Neveu PJ. Brain lateralization and immunomodulation. Int J Neurosci 1993;70:135-43
61. Coleman-Mesches K, McGaugh JL. Differential involvement of the right and left amygdalae in expression of memory for aversively motivated training. Brain Res 1995;670:75-81
62. Coleman-Mesches K, McGaugh JL. Differential effects of pretraining inactivation of the right or left amygdala on retention of inhibitory avoidance training. Behav Neurosci 1995;109:642-47
63. Coleman-Mesches K, McGaugh JL. Muscimol injected into the right or left amygdaloid complex differentially affects retention performance following aversively motivated training. Brain Res 1995;676:183-88
64. Belcheva I, Belcheva S, Petkov VV, Petkov VD. Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala. Neuropharmacology 1994;33:995-1002
65. Robinson RG. Differential behavioral and biochemical effects of right and left hemispheric cerebral infarction in the rat. Science 1979;205:707-10
66. Kubos KL, Pearlson GD, Robinson RG. Intracortical kainic acid induces an asymmetrical behavioral response in the rat. Brain Res 1982;239:303-9
67. Pearlson GD, Robinson RG. Suction lesions of the frontal cerebral cortex in the rat induce asymmetrical behavioral and catecholaminergic responses. Brain Res 1981;218:233-42
68. Dewberry RG, Lipsey JR, Saad K, Moran TH, Robinson RG. Lateralized response to cortical injury in the rat: Interhemispheric interaction. Behav Neurosci 1986;100:556-62
69. Vlajkovic S, Nikolic V, Nikolic A, Milanovic S, Jankovic BD. Asymmetrical modulation of immune reactivity in left-and right-biased rats after ipsilateral ablation of the prefrontal, parietal and occipital brain neocortex. Int J Neurosci 1994;78:123-34
70. Sullivan RM, Szechtman H. Left/right nigrostriatal asymmetry in susceptibility to neurotoxic dopamine depletion with 6-hydroxydopamine in rats. Neurosci Lett 1994;170:83-86
71. Hachinski VC, Oppenheimer SM, Wilson JX, Guiraudon C, Cechetto DF. Asymmetry of sympathetic consequences of experimental stroke. Arch Neurol 1992;49:697-702
72. Carlson JN, Visker KE, Keller RW, et al. Left and right 6-hydroxydopamine lesions of the medial prefrontal cortex differentially alter subcortical dopamine utilization and the behavioral response to stress. Brain Res 1996;711:1-9
73. Barneoud P, Le Moal M, Neveu PJ. Asymmetrical effects of cortical ablation on brain monoamines in mice. Int J Neurosci 1991;56: 283-94
74. Moossy J, Zubenko GS, Martinez AJ, Rao GR, Kopp U, Hanin I. Lateralization of brain morphologic and cholinergic abnormalities in Alzheimer's disease. Arch Neurol 1989;46:639-42
75. Crystal HA, Horoupian DS, Katzman R, Jotkowitz S. Biopsyproved Alzheimer disease presenting as a right parietal lobe syndrome. Ann Neurol 1981;12:186-88
76. Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 1982;105:313-30
77. Vereecken TH, Vogels OJ, Nieuwenhuys R. Neuron loss and shrinkage in the amygdala in Alzheimer's disease. Neurobiol Aging 1994;15:45-54
78. Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Arch Neurol 1986;43:882-85
79. Chase TN, Foster NL, Fedio P, Brooks R, Mansi L, Di Chiro G. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography. Ann Neurol 1984;15 Suppl: S170-S174
80. Friedland RP, Budinger TF, Koss E, Ober BA. Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett 1985;53:235-40
81. Haxby JV, Duara R, Grady CL, Cutler NR, Rapoport SI. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J Cereb Blood Flow Metab 1985;5:193-200
82. Duara R, Grady C, Haxby J, et al. Positron emission tomography in Alzheimer's disease. Neurology 1986;36:879-87
83. Haxby JV, Grady CL, Friedland RP, Rapoport SI. Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early dementia of the Alzheimer type: Longitudinal confirmation. J Neural Transm Suppl 1987;24:49-53
84. Grady CL, Haxby JV, Schlageter NL, Berg G, Rapoport SI. Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type. Neurology 1986;36:1390-92
85. Haxby JV, Grady CL, Koss E, et al. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 1990;47:753-60
86. O'Brien JT, Eagger S, Syed GM, Sahakian BJ, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:1182-87
87. Loewenstein DA, Barker WW, Chang JY, et al. Predominant left hemisphere metabolic dysfunction in dementia. Arch Neurol 1989;46:146-52
88. Seltzer B, Sherwin I. A comparison of clinical features in early-and late-onset primary degenerative dementia. One entity or two? Arch Neurol 1983;40:143-46
89. Motomura N, Seo T. Lateral hemispheric asymmetries in senile dementia of Alzheimer's type (SDAT) assessed by I-123 IMP SPECT imaging: A preliminary report. Int J Neurosci 1992;63:1-3
90. Naugle RI, Cullum CM, Bigler ED, Massman PJ. Neuropsychological and computerized axial tomography volume characteristics of empirically derived dementia subgroups. J Nerv Ment Dis 1985;173:596-604
91. Ichimiya A, Herholz K, Mielke R, Kessler J, Slansky I, Heiss WD. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: A factor analytical study. J Neurol Sci 1994;123:11-17